← Open Payments lookup

GABOR FEKETE: Open Payments

NPI 1306535919 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,387 in 40 payments from 12 companies in 2025. Trend: 2023 $458 · 2024 $1,913 · 2025 $2,387

Food & beverage: $2,387
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$593
Intra-Sana Laboratories12$262
ABBVIE INC.3$260
Amgen Inc.6$247
United Therapeutics Corporation3$241
Astellas Pharma US Inc3$149
Avadel CNS Pharmaceuticals, LLC1$130
Novo Nordisk Inc1$125
KYOWA KIRIN, INC.1$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$118

Products named: RELTONE 200 MG, AIRSUPRA, TYVASO, Repatha, Veozah, VRAYLAR, LUMRYZ, Wegovy.

Industry payments across NV — which companies pay providers there.